Friday, September 12, 2014

Best Diversified Bank Stocks To Own Right Now

What can you expect from a stock fund? That depends on how bullish the fund is, and whether you get a bull or a bear market next. Funds that are at the head of the class when stock prices are going up are likely to do worst when prices are headed down. Defensive funds that lag in bull markets do the best in bear ones.

That dichotomy is behind the fund rating system that Forbes has used since the early 1960s. We award separate performance grades for bull and bear markets. We think it�� more informative than the usual straight-line performance history.

Here�� what�� wrong with just comparing funds over some fixed number of years: Unless your measurement period happens to cover a full market cycle, it�� likely to give you a very distorted view of the abilities of the fund manager. Just now a five-year performance comparison would make any high-risk fund look devilishly clever. But that sort of fund is likely to get killed in the next correction

To grade funds, we look at what happened over two full cycles of up and down markets. That takes us back to August 2000. There are 942 funds buying predominantly U.S. stocks that have been around long enough to be evaluated this way. (Funds with less than $50 million of assets are excluded.)

Top Healthcare Technology Stocks To Watch Right Now: Flamel Technologies S.A.(FLML)

Flamel Technologies S.A., a biopharmaceutical company, engages in the development and commercialization of controlled-release therapeutic products based on its proprietary polymer based technology in the United Kingdom, Ireland, the United States, France, and Europe. The company develops nanogel Medusa technology, which is intended to provide controlled release following injection of therapeutic proteins, peptides, and other molecules; a microparticle adaptation of the Medusa platform that is intended for use in the delivery of smaller proteins and peptides; and Micropump technology, a microparticle technology for oral administration of small molecule drugs with applications in controlled-release, taste-masking, and bioavailability enhancement; and Trigger-Lock technology, an adaptation based on Micropump technology, which is intended to minimize the misuse and abuse of medications subject to abuse. Its principal product based on Micropump technology is Coreg CR, which is intended for the treatment of moderate to severe heart failure and left ventricular dysfunction following myocardial infarction. The company?s products under development based upon Medusa technology include Interferon-alpha, a naturally occurring protein that the body uses for the treatment of Hepatitis C virus and as a immune response; and FT-105, an injectable insulin formulation for diabetic patients. Its products based on its Micropump technology comprise LiquiTime for the elderly and pediatric patient patients, or others who have difficulty swallowing. The company has strategic alliance with Baxter International, Inc.; GlaxoSmithKline; Merck Serono; and Pfizer Inc, as well as has a joint development agreement with Digna Biotech, S.L. Flamel Technologies S.A. was founded in 1990 and is headquartered in Venissieux, France.

Advisors' Opinion:
  • [By Anna Prior]

    Flamel Technologies SA(FLML) said the U.S. Food and Drug Administration has approved the company’s new drug application for Vazculep, an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. American depositary shares rose 5.1% to $14.78 in premarket trading.

  • [By Garrett Cook]

    Healthcare shares gained 0.81 percent in the US market on Friday. Top gainers in the sector included Shire plc (NASDAQ: SHPG), StemCells (NASDAQ: STEM), and Flamel Technologies SA (NASDAQ: FLML).

Best Diversified Bank Stocks To Own Right Now: Sonus Networks Inc.(SONS)

Sonus Networks, Inc. provides voice and multimedia infrastructure solutions. The company offers session border control (SBC), voice over Internet protocol (VoIP), and access and VoIP media gateway solutions that allow the delivery of voice and multimedia sessions over IP networks. Its products include GSX9000 Open Services Switch that enables voice traffic to be transported over packet networks; GSX4000 Open Services Switch; NBS9000 Network Border Switch that permits service providers to transform their time division multiplexing networks to IP; PSX Policy & Routing Server, which translates business policies into actual call control, routing, and service selection decisions; NBS5200 Network Border Switch that provides SBC functionality; and ASX Call Feature Server that provides local area calling and regulatory features for residential and enterprise markets. The company also offers Network Analytics Suite of performance management products, including NetScore network perf ormance analysis tool, NetAssure voice quality monitoring tool, and NetEng network audit and visualization engine that are used for the collection, monitoring, reporting, and notification of performance metrics. In addition, it provides professional consulting and services to support its IP communication solutions; and program management, network deployment design, softswitch and subscriber database design, network verification and audit, custom application and adaptor development, OSS and API integration, migration and upgrade, and managed services. The company serves long-distance and local exchange carriers, Internet service providers, wireless operators, cable operators, financial institutions, retailers, state and local governments, and multinational corporations. It sells its products primarily through a direct sales force in the United States, Europe, the Asia-Pacific, and the Middle East. Sonus Networks, Inc. was founded in 1997 and is headquartered in Westford, Mass achusetts.

Advisors' Opinion:
  • [By Lee Jackson]

    Sonus Networks Inc. (NASDAQ: SONS) was recently named to the 2013 InformationWeek 500 list of top technology innovators across the country. In July the company authorized a repurchase program to buy back up to $100 million of their stock. Lazard has a Buy rating on the stock and a $4.50 price target. The consensus target is at $4.30, and the stock closed yesterday at $3.41.

  • [By Roberto Pedone]

    One networking player that's starting to move within range of triggering a big breakout trade is Sonus Networks (SONS), which provides networked solutions for communications service providers and enterprises in the U.S., Europe, the Middle East, Africa, and the Asia Pacific. This stock has been red hot so far in 2013, with shares up 104%.

    If you take a look at the chart for Sonus Networks, you'll notice that this stock has been trending sideways for the past month, with shares moving between $3.25 on the downside and $3.72 on the upside. Shares of SONS have been finding support over the last month each time the stock has pulled back to its 50-day moving average. This stock is now starting to trend a bit higher and move within range of triggering a breakout trade above the upper-end of its sideways consolidating chart pattern.

    Traders should now look for long-biased trades in SONS if it manages to break out above some near-term overhead resistance at $3.56 to $3.59 a share and then once it takes out its 52-week high at $3.72 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 2.50 million shares. If that breakout hits soon, then SONS will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $5 to $5.50 a share.

    Traders can look to buy SONS off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3.33 to $3.25 a share, or right below more support at $3.10 a share. One could also buy SONS off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Evan Niu, CFA]

    What: Shares of Sonus Networks (NASDAQ: SONS  ) have popped today by upwards of 17% after the company reported first-quarter earnings.

    So what: First quarter sales totaled $63.3 million, which turned into a non-GAAP net loss of $0.02 per share. Investors were expecting just $61.1 million up top and an adjusted loss of $0.03 per share, meaning the figures were a beat relative to consensus estimates. Session border controller, or SBC, revenue was up 77% to $30 million.

  • [By Ben Fox Rubin]

    Sonus Networks Inc.(SONS) agreed to buy Performance Technologies Inc.(PTIX), a supplier of network communications products, for $3.75 a share, a 26% premium of Thursday’s close, or $42 million. The companies said the deal was worth $30 million, net of Performance Technologies’ cash and excluding acquisition costs. Performance Technologies shares jumped 24% to $3.70 premarket, just under the offer price.

Best Diversified Bank Stocks To Own Right Now: Prosensa Holding NV (RNA)

Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company�� primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington�� disease. The Company�� clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company�� platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.

DMD is a rare, severe muscle wasting disease that occurs in up to 1 in 3,500 male births. It is commonly diagnosed between the ages of three to five, when boys begin to show signs of impaired motor development. PRO044, the Company�� product candidate, addresses a separate sub-population of DMD patients. The Company developed PRO044 using its exon-skipping technology to generate a product candidate with the same mechanism of action that is used by drisapersen.

Advisors' Opinion:
  • [By Sean Williams]

    What: Shares of Prosensa (NASDAQ: RNA  ) , a clinical-stage developer of RNA-modulating therapeutic agents for genetic disorders, jumped as much as 50% after reporting additional clinical findings on drisapersen at the JPMorgan Healthcare Conference.

  • [By Leo Sun]

    However, these three biotech stocks -- Amarin (NASDAQ: AMRN  ) , Dendreon (NASDAQ: DNDN  ) , Prosensa (NASDAQ: RNA  ) -- don't fit that category at all. Read on to understand why these dogs of the sector should never be mistaken as underdogs.

  • [By Keith Speights]

    An "alley-oop" from the opponent
    Prosensa (NASDAQ: RNA  ) shares made something of a slam dunk this week, jumping more than 16%. That dunk was made with what amounts to an "alley-oop" from its primary rival, Sarepta Therapeutics (NASDAQ: SRPT  ) .

  • [By John Udovich]

    It should also be mentioned that earlier in the week, GlaxoSmithKline plc (NYSE: GSK) returned full rights of Duchenne muscular dystrophy drug drisapersen to their partner�Prosensa Holding NV (NASDAQ: RNA) and that news sent shares down 12.48% on�Monday. Moreover,�Prosensa Holding also sank some 70% last fall when Drisapersen failed a phase 3 trial by missing a primary endpoint measuring for how far patients could walk over the course of six minutes (the improvement�wasn't significantly better than the placebo).�However, Prosensa Holding also rose 24.37% yesterday after announcing�initial findings from further analyses from the aggregate data for drisapersen, with the CEO saying:

Best Diversified Bank Stocks To Own Right Now: Town Sports International Holdings Inc.(CLUB)

Town Sports International Holdings, Inc., together with its subsidiaries, owns and operates fitness clubs in the northeast and mid-Atlantic regions of the United States. Its facilities include cardiovascular equipment; free weight and strength equipment; group exercise and cycling studios; the entertainment system network; locker rooms, including shower facilities and towel services; and other amenities, such as saunas, babysitting, and a pro-shop. The company also provides swimming pools, and racquet and basketball courts; and programs, which include small group training, children?s programs, and other programs targeting adult members. As of December 31, 2011, it operated 160 fitness clubs comprising 108 New York Sports Clubs, 25 Boston Sports Clubs, 18 Washington Sports Clubs, and 6 Philadelphia Sports Clubs, as well as 3 clubs located in Switzerland. The company is based in New York, New York.

Advisors' Opinion:
  • [By gurujx]

    Town Sports International Holdings Inc (CLUB) Reached the 3-year Low of $5.82

    The prices of Town Sports International Holdings Inc (CLUB) shares have declined to close to the 3-year low of $5.82, which is 62.2% off the 3-year high of $14.96.

Best Diversified Bank Stocks To Own Right Now: OM Group Inc.(OMG)

OM Group, Inc. develops, produces, and markets specialty chemicals, advanced materials, and electrochemical energy storage products worldwide. The company operates in three segments: Advanced Materials, Specialty Chemicals, and Battery Technologies. The Advanced Materials segment manufactures inorganic products using unrefined cobalt and other metals and serves the battery materials, powder metallurgy, ceramics, and chemical end markets. It offers cobalt powders, precursors, chemicals, pigments and ceramics, and various raw materials. These products enhance the electrical conduction of rechargeable batteries, as well as strengthen and add durability to diamond and machine cutting tools and drilling equipment. The Specialty Chemicals segment offers electronic chemicals for the printed circuit board, memory disk, general metal finishing, electronic packaging and finishing, and photovoltaic markets. This segment also provides advanced organics comprising additives and driers for paints, and printing inks; rubber adhesion promoters for tires; composite and other catalysts for chemicals; and fuel oil additives, lubricants, and grease additives. In addition, it offers ultra pure chemicals used in the manufacture of electronic and computer components, such as semiconductors, wafers, and liquid crystal displays; and photo-imaging masks, including high-purity quartz or glass plates containing precision, microscopic images of integrated circuits; and reticles for the semiconductor, optoelectronics, and microelectronics industries under the Compugraphics brand name. The Battery Technologies segment provides battery products, primary and secondary batteries, battery management systems, battery chargers, and energetic devices for defense applications; primary and secondary batteries for satellites, aircraft, and the packaging of cells; and miniature batteries to power implantable medical devices. The company was founded in 1991 and is headquartered in Cle veland, Ohio.

Advisors' Opinion:
  • [By Rich Smith]

    KMG Chemicals (NYSE: KMG  ) is buying OM Group's (NYSE: OMG  ) Ultra Pure Chemicals subsidiaries in the U.S., U.K., Singapore, and perhaps in France as well.

Best Diversified Bank Stocks To Own Right Now: Herman Miller Inc.(MLHR)

Herman Miller, Inc. engages in the research, design, manufacture, and distribution of interior furniture systems, products, and related services worldwide. It also provides modular systems under the Action Office, Canvas Office Landscape, Ethospace, Resolve, My Studio Environments, and Vivo Interiors brand names; seating products under the Embody, Aeron, Mirra, Setu, Celle, Equa, and Ergon brand names; and storage products under the Meridian and Tu brand names. In addition, the company offers wooden casegoods under the Geiger brand name; freestanding furniture products under the Abak, Intent, Sense, and Envelop brand name; and ergonomic solutions. It markets its products for office, healthcare, industrial, educational, and residential settings through its sales staff, own dealer network, independent dealers and retailers, and independent contract office furniture dealers, as well as through Internet. The company was founded in 1905 and is based in Zeeland, Michigan.

Advisors' Opinion:
  • [By Rich Smith]

    Zeeland, Mich.-based Herman Miller (NASDAQ: MLHR  ) is buying New York's Maharam Fabric Corporation in an all-cash deal valued at $156 million.

Best Diversified Bank Stocks To Own Right Now: Vishay Precision Group Inc.(VPG)

Vishay Precision Group, Inc. designs, manufactures, and markets components based on resistive foil technology, sensors, and sensor-based systems in the United States, Europe, and Asia. The company?s products include precision foil resistors, foil strain gages, transducers and load cells, modules, instruments, weighing and control systems, and PhotoStress coatings and instruments; and sensors that convert mechanical inputs into an electronic signal for display, processing, interpretation, or control by the company?s instrumentation and systems products. Its products are used in waste management, bulk hauling, logging, scales manufacturing, engineering systems, pharmaceutical, oil, chemical, steel, paper, and food industries, as well as in military/aerospace, medical, agriculture, and construction markets. The company sells its products through original equipment manufacturers, electronic manufacturing services companies, and independent distributors, as well as directly t o end-use customers. Vishay Precision Group, Inc. was founded in 1962 and is headquartered in Malvern, Pennsylvania.

Advisors' Opinion:
  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Vishay Precision Group (NYSE: VPG  ) , whose recent revenue and earnings are plotted below.

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Vishay Precision Group (NYSE: VPG  ) , whose recent revenue and earnings are plotted below.

No comments:

Post a Comment